MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases
Go back to MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 3.89 -0.05 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.94 | 52 Week High | $2.51 | |||
| Open | $3.95 | 52 Week Low | $0.41 | |||
| Day High | $4.06 | P/E | N/A | |||
| Day Low | $3.88 | EPS | $-0.64 | |||
| Volume | 3,562,816 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 538.30 +1.71 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $536.59 | 52 Week High | $164.04 | |||
| Open | $541.25 | 52 Week Low | $97.52 | |||
| Day High | $541.53 | P/E | 98.41 | |||
| Day Low | $533.49 | EPS | $5.47 | |||
| Volume | 620,875 | |||||
